India's Tatva Chintan Pharma Chem rises as ICICI Securities raises target price
Wed 09:16
BUZZ-India's Tatva Chintan Pharma Chem rises as ICICI Securities raises target price ** ICICI Securities raises PT on Tatva Chintan Pharma Chem TATV.NS to 2,385 rupees from 1,955 rupees, maintains "buy" rating
** TATV September-quarter consolidated net profit increased 116.2% Y/Y, and consolidated revenue rose 75% Y/Y, co reported on Monday after market hours
** Revenue expansion on solid performance across segments - ICICI Securities analyst rated 4 of 5 stars for overall rating accuracy
** Raises FY27/FY28 EBITDA estimates by 8.1%/3.6%, revenue estimates by 11.8%/7.8%
** Says co expects margin headwinds to gradually normalise from Q3FY27
** Stock up 0.6% at 1,914.70 rupees on the day; YTD up 43.5%
(Reporting by Payel Das in Bengaluru)
Recent news on Tatva Chintan Pharma Chem
See all newsIndia's Tatva Chintan Pharma Chem rises as ICICI Securities raises target price
Brief: Tatva Chintan Pharma Chem Says Sept-Quarter Consol Net Profit 214.51 Million Rupees
India's Tatva Chintan Pharma hits upper circuit as Q1 profit more than doubles
Brief: Tatva Chintan Pharma Chem Sept Quarter Consol Net Profit 99.2 Million Rupees
India's Tatva Chintan Pharma Chem soars on Q1 profit jump